INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $28,785,000 | +10.1% | 1,336,368 | +0.8% | 5.06% | -15.5% |
| Q2 2022 | $26,156,000 | -42.9% | 1,326,368 | -31.9% | 5.99% | -44.7% |
| Q1 2022 | $45,796,000 | +28.0% | 1,948,784 | +48.4% | 10.83% | -8.2% |
| Q4 2021 | $35,783,000 | -1.1% | 1,313,607 | 0.0% | 11.80% | -10.3% |
| Q3 2021 | $36,177,000 | -1.0% | 1,313,607 | +2.3% | 13.16% | -12.4% |
| Q2 2021 | $36,539,000 | +11.5% | 1,283,887 | +33.5% | 15.02% | +8.8% |
| Q1 2021 | $32,759,000 | +2.3% | 961,797 | 0.0% | 13.81% | +20.6% |
| Q4 2020 | $32,018,000 | -5.7% | 961,797 | -9.0% | 11.45% | -20.4% |
| Q3 2020 | $33,965,000 | +22.0% | 1,056,797 | +4.6% | 14.39% | +15.9% |
| Q2 2020 | $27,837,000 | +70.1% | 1,010,797 | -1.0% | 12.42% | +25.1% |
| Q1 2020 | $16,363,000 | -30.7% | 1,020,797 | +3.2% | 9.92% | -30.7% |
| Q4 2019 | $23,617,000 | – | 988,999 | – | 14.31% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |